MRTX

Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion

October 8, 2023 · Breaking News

Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion. The pharmaceutical giant announced it will pay…

MRTX Stock Price | Mirati Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

August 9, 2023 · Breaking News

Mirati Therapeutics Inc. Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm’s products target the genetic and immunological promoters…